宮田 純

Medicine & Life Sciences

1. 1-Acylglycerophosphocholine O-Acyltransferase 19%
2. 12-15-lipoxygenase 18%
3. 17,18-epoxy-5,8,11,14-eicosatetraenoic acid 23%
4. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 20%
5. Adrenal Cortex Hormones 30%
6. Allergic Bronchopulmonary Aspergillosis 16%
7. Annular Erythema 19%
8. Asthma 100%
9. benralizumab 40%
10. Bronchoalveolar Lavage Fluid 23%
11. Chronic Obstructive Pulmonary Disease 25%
12. Coinfection 21%
13. cysteinyl-leukotriene 42%
14. Cytokines 16%
15. Docosahexaenoic Acids 20%
16. Eicosapentaenoic Acid 20%
17. Eosinophils 88%
18. Fatty Acids 16%
19. guanidine thiocyanate 19%
20. Inflammation 46%
21. Interleukin-33 29%
22. Japan 18%
23. lipoxin A4 17%
24. Lung 29%
25. Macrophages 18%
26. Mucus 16%
27. Nanopore Sequencing 18%
28. Nasal Polyps 17%
29. Necrotizing Pneumonia 17%
30. Nocardia Infections 16%
31. Non-Small Cell Lung Carcinoma 19%
32. Omalizumab 16%
33. Omega-3 Fatty Acids 18%
34. Ovalbumin 20%
35. pazopanib 16%
36. Pneumonia 15%
37. protectin D1 20%
38. Proteogenomics 18%
39. resiquimod 18%
40. S 1 (combination) 18%
41. Sepsis 17%
42. Serum 16%
43. Sleep Apnea Syndromes 16%
44. Smoke 19%
45. Therapeutics 22%
46. Thromboxane Receptors 16%
47. thymic stromal lymphopoietin 16%
48. Tiotropium Bromide 16%
49. Tobacco Products 20%
50. Toll-Like Receptor 7 16%